Angeborene Bindegewebserkrankungen mit skelettalem Phänotyp

Rolf E. Brenner; Rita Taurman

doi:10.1055/s-0042-109019

Orthopädie und Unfallchirurgie up2date, Inhaltsverzeichnis

Orthopädie und Unfallchirurgie up2date 2017; 12(02): 131-153
DOI: 10.1055/s-0042-109019

Grundlagen

Georg Thieme Verlag KG Stuttgart · New York

Angeborene Bindegewebserkrankungen mit skelettalem Phänotyp

Autoren

Rolf E. Brenner
Rita Taurman

Abstract

Alle Artikel dieser Rubrik

Dieser Beitrag beschäftigt sich mit den kongenitalen Bindegewebserkrankungen Osteogenesis imperfecta, Ehlers-Danlos- und Marfan-Syndrom. Für diese Entitäten werden die derzeit aktuellen Klassifikationen, diagnostischen Möglichkeiten, Abgrenzungen gegenüber phänotypisch ähnlichen Krankheitsbildern sowie konservative und operative Therapieoptionen dargestellt.

Volltext

Referenzen

Literatur
1 Brenner RE, Schiller B, Pontz BF. et al. Osteogenesis imperfecta in Kindheit und Adoleszenz. Monatsschr Kinderheilkd 1993; 141: 940-945
2 Wirth T. Osteogenesis imperfecta. Orthopäde 2012; 41: 773-784
3 Forlino A, Marini JC. Osteogenesis imperfecta. Lancet 2016; 387: 1657-1671
4 Glorieux FH, Rauch F, Plotkin H. et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 2000; 15: 1650-1658
5 Cho TJ, Lee KE, Lee SK. et al. A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Human Genet 2012; 91: 343-348
6 Semler O, Garbes L, Keupp K. et al. A mutation in the 5′-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Human Genet 2012; 91: 349-357
7 Rauch F, Husseini A, Roughley P. et al. Lack of circulating pigment epithelium-derived factor is a marker of osteogenesis imperfecta type VI. J Clin Endocrinol Metab 2012; 97: E1550-E1556
8 Glorieux FH, Ward LM, Rauch F. et al. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 2002; 17: 30-38
9 Van Dijk FS, Sillence DO. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A 2014; 164?A: 1470-1481
10 Warman ML, Cormier-Daire V, Hall C. et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011; 155?A: 943-968
11 Pereira EM. Clinical perspectives on osteogenesis imperfecta versus non-accidental injury. Am J Med Genet C Sem Med Genet 2015; 169: 302-306
12 Ha-Vinh R, Alanay Y, Bank RA. et al. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet A 2004; 131: 115-120
13 Kelley BP, Malfait F, Bonafe L. et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res 2011; 26: 666-672
14 Balasubramanian M, Pollitt RC, Chandler KE. et al. CRTAP mutation in a patient with Cole-Carpenter syndrome. Am J Med Genet A 2015; 167?A: 587-591
15 Garbes L, Kim K, Riess A. et al. Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta. Am J Human Genet 2015; 96: 432-439
16 Rauch F, Fahiminiya S, Majewski J. et al. Cole-Carpenter syndrome is caused by a heterozygous missense mutation in P4HB. Am J Human Genet 2015; 96: 425-431
17 Hartikka H, Makitie O, Mannikko M. et al. Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. J Bone Miner Res 2005; 20: 783-789
18 Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep 2016; 14: 95-105
19 Brunetti G, Marzano F, Colucci S. et al. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. Endocrine 2012; 42: 266-271
20 Bronicki LM, Stevenson RE, Spranger JW. Beyond osteogenesis imperfecta: Causes of fractures during infancy and childhood. Am J Med Genet C Semin Med Genet 2015; 169: 314-327
21 Brenner R. Frakturhäufung. In: Michalk D, Schönau E. Hrsg. Differenzialdiagnose Pädiatrie. 3. Aufl.. Berlin: Urban & Fischer, Elsevier; 2011: 631-634
22 LoMauro A, Pochintesta S, Romei M. et al. Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta. PloS One 2012; 7: e35965
23 Arponen H, Makitie O, Haukka J. et al. Prevalence and natural course of craniocervical junction anomalies during growth in patients with osteogenesis imperfecta. J Bone Miner Res 2012; 27: 1142-1149
24 Brenner RE, Vetter U, Bollen AM. et al. Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 1994; 9: 993-997
25 Land C, Rauch F, Munns CF. et al. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment. Bone 2006; 39: 901-906
26 Sato A, Ouellet J, Muneta T. et al. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations – genotype-phenotype correlations and effect of bisphosphonate treatment. Bone 2016; 86: 53-57
27 Dwan K, Phillipi CA, Steiner RD. et al. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev 2014; (07) CD005088
28 Hald JD, Evangelou E, Langdahl BL. et al. Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials. J Bone Miner Res 2015; 30: 929-933
29 Vetter U, Pontz B, Zauner E. et al. Osteogenesis imperfecta: a clinical study of the first ten years of life. Calc Tissue Int 1992; 50: 36-41
30 Glorieux FH, Bishop NJ, Plotkin H. et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. New Engl J Med 1998; 339: 947-952
31 Gatti D, Antoniazzi F, Prizzi R. et al. Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res 2005; 20: 758-763
32 Ward LM, Rauch F, Whyte MP. et al. Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 2011; 96: 355-364
33 Bonafé L, Giunta C, Hasler C. et al. Osteogenesis imperfecta: Klinik, Diagnose und Management vom Kindes- bis ins Erwachsenenalter. Schweiz Med Forum 2013; 13: 925-931
34 Brizola E, Shapiro JR. Bisphosphonate treatment of children and adults with osteogenesis imperfecta: unanswered questions. Calc Tissue Int 2015; 97: 101-103
35 Marini JC. Bone: Use of bisphosphonates in children-proceed with caution. Nat Rev Endocrinol 2009; 5: 241-243
36 Vasanwala RF, Sanghrajka A, Bishop NJ. et al. Recurrent proximal femur fractures in a teenager with osteogenesis imperfecta on continuous bisphosphonate therapy: Are we overtreating?. J Bone Miner Res 2016; 31: 1449-1454
37 Munns CF, Rauch F, Zeitlin L. et al. Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 2004; 19: 1779-1786
38 Rauch F, Travers R, Glorieux FH. Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy. J Clin Endocrinol Metab 2006; 91: 511-516
39 Lindahl K, Langdahl B, Ljunggren O. et al. Treatment of osteogenesis imperfecta in adults. Eur J Endocrinol 2014; 171: R79-R90
40 Ranganath P, Stephen J, Iyengar R. et al. Worsening of callus hyperplasia after bisphosphonate treatment in type V osteogenesis imperfecta. Indian Pediat 2016; 53: 250-252
41 Zeitlin L, Rauch F, Travers R. et al. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V. Bone 2006; 38: 13-20
42 Land C, Rauch F, Travers R. et al. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone 2007; 40: 638-644
43 Hoyer-Kuhn H, Netzer C, Koerber F. et al. Two yearsʼ experience with denosumab for children with osteogenesis imperfecta type VI. Orphanet J Rare Dis 2014; 9: 145
44 Cheung MS, Glorieux FH, Rauch F. Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 2007; 22: 1181-1186
45 Bailey RW, Dubow HI. Studies of longitudinal bone growth resulting in an extensible nail. Surg Forum 1963; 14: 455-458
46 Wörsdörfer O, Vetter U, Brenner R. Femurosteosynthesen mit dem Teleskopnagel nach Bailey-Dubow bei Osteogenesis imperfecta. Oper Orthop Traumatol 1990; 2: 122-130
47 Karbowski A, Schwitalle M, Brenner R. et al. Experience with Bailey-Dubow rodding in children with osteogenesis imperfecta. Z Kinderchir 2000; 10: 119-124
48 Birke O, Davies N, Latimer M. et al. Experience with the Fassier-Duval telescopic rod: first 24 consecutive cases with a minimum of 1-year follow-up. J Pediat Orthop 2011; 31: 458-464
49 Meurer A, Lewens T, Schmitt D. et al. Diagnostik und Therapie der Osteogenesis imperfecta. Orthopäde 2008; 37: 17-23
50 Döderlein L, Wenz W, Schneider U. Der Knickplattfuß. Berlin, Heidelberg: Springer; 2002
51 Ibrahim AG, Crockard HA. Basilar impression and osteogenesis imperfecta: a 21-year retrospective review of outcomes in 20 patients. J Neurosurg Spine 2007; 7: 594-600
52 Sobey G. Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests. Arch Dis Child 2015; 100: 57-61
53 Beighton P, De Paepe A, Steinmann B. et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998; 77: 31-37
54 Beighton P, Solomon L, Soskolne CL. Articular mobility in an African population. Ann Rheum Dis 1973; 32: 413-418
55 Eller-Vainicher C, Bassotti A, Imeraj A. et al. Bone involvement in adult patients affected with Ehlers-Danlos syndrome. Osteoporos Int 2016; 27: 2525-2531
56 Mazziotti G, Dordoni C, Doga M. et al. High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome. Bone 2016; 84: 88-92
57 Hausser I, Anton-Lamprecht I. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I–IV as a means of diagnostics and classification. Human Genet 1994; 93: 394-407
58 Malfait F, Wenstrup RJ, De Paepe A. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 2010; 12: 597-605
59 Castori M, Colombi M. Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet 2015; 169?C: 1-5
60 Zweers MC, Bristow J, Steijlen PM. et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Human Genet 2003; 73: 214-217
61 Brinckmann J, Acil Y, Feshchenko S. et al. Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a novel point mutation (W612C). Arch Dermatol Res 1998; 290: 181-186
62 Acil Y, Vetter U, Brenner R. et al. Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dermatol 1995; 33: 522-524
63 Lehmann HW, Mundlos S, Winterpacht A. et al. Ehlers-Danlos syndrome type VII: phenotype and genotype. Arch Dermatol Res 1994; 286: 425-428
64 Malfait F, De Coster P, Hausser I. et al. The natural history, including orofacial features of three patients with Ehlers-Danlos syndrome, dermatosparaxis type (EDS type VIIC). Am J Med Genet A 2004; 131: 18-28
65 Burch GH, Gong Y, Liu W. et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nature Genet 1997; 17: 104-108
66 Baumann M, Giunta C, Krabichler B. et al. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Human Genet 2012; 90: 201-216
67 Janecke AR, Li B, Boehm M. et al. The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. Am J Med Genet A 2016; 170: 103-115
68 Salter CG, Davies JH, Moon RJ. et al. Further defining the phenotypic spectrum of B4GALT7 mutations. Am J Med Genet A 2016; 170: 1556-1563
69 Cabral WA, Makareeva E, Colige A. et al. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing. J Biol Chem 2005; 280: 19259-19269
70 Kirschner J, Hausser I, Zou Y. et al. Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes. Am J Med Genet A 2005; 132?A: 296-301
71 Hefti F. Kinderorthopädie in der Praxis. Berlin, Heidelberg: Springer; 2015
72 Akpinar S, Gogus A, Talu U. et al. Surgical management of the spinal deformity in Ehlers-Danlos syndrome type VI. Eur Spine J 2003; 12: 135-140
73 Dietz HC, Cutting GR, Pyeritz RE. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (London) 1991; 352: 337-339
74 Tiecke F, Katzke S, Booms P. et al. Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24–40. Eur J Human Genet 2001; 9: 13-21
75 Neptune ER, Frischmeyer PA, Arking DE. et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nature Genet 2003; 33: 407-411
76 Cannaerts E, van de Beek G, Verstraeten A. et al. TGF-beta signalopathies as a paradigm for translational medicine. Eur Med Genet 2015; 58: 695-703
77 Loeys BL, Dietz HC, Braverman AC. et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-485
78 De Paepe A, Devereux RB, Dietz HC. et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417-426
79 Doyle AJ, Doyle JJ, Bessling SL. et al. Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nature Genet 2012; 44: 1249-1254
80 Callewaert BL, Loeys BL, Ficcadenti A. et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. Human Mutat 2009; 30: 334-341
81 Chandra A, Charteris D. Molecular pathogenesis and management strategies of ectopia lentis. Eye 2014; 28: 162-168
82 Singh MN, Lacro RV. Recent Clinical drug trials evidence in Marfan syndrome and clinical implications. Can J Cardiol 2016; 32: 66-77
83 Herring J. Tachdjianʼs pediatric Orthopaedics. 5th ed. Philadelphia: Saunders; 2013
84 Gjolaj JP, Sponseller PD, Shah SA. et al. Spinal deformity correction in Marfan syndrome versus adolescent idiopathic scoliosis: learning from the differences. Spine 2012; 37: 1558-1565
85 Van de Velde S, Fillman R, Yandow S. Protrusio acetabuli in Marfan Syndrome. J Bone Joint Surg 2006; 88: 639-646